Kaslow; David C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kaslow; David C..The latest application filed is for "methods of immunization with varicella zoster virus antigen".

Company Profile

0.12.17

Kaslow; David C. - Seattle WA
KASLOW; David C. - Wayne PA US
Kaslow; David C. - Rancho Santa Fe CA US
Kaslow; David C. - Bryn Mawr PA
Kaslow, David C - Rancho Santa Fe CA
Kaslow; David C. - Kensington MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of immunization with varicella zoster virus antigen Grant 10,350,289 - Meyer , et al. July 16, 2	2019-07-16
Methods Of Immunization With Varicella Zoster Virus Antigen App 20160193324 - Meyer; Brian K. ; et al.	2016-07-07
Hepatitis C virus vaccine Grant 8,530,234 - Kaslow , et al. September 10, 2	2013-09-10
Hepatitis C virus vaccine Grant 8,142,794 - Emini , et al. March 27, 2	2012-03-27
Hepatitis C Virus Vaccine App 20100129901 - Kaslow; David C. ; et al.	2010-05-27
Hepatitis C virus vaccine Grant 7,598,362 - Emini , et al. October 6, 2	2009-10-06
Hepatitis C Virus Vaccine App 20090233992 - Emini; Emilio A. ; et al.	2009-09-17
Vaccines For Blocking Transmission Of Plasmodium Vivax App 20080274132 - KASLOW; David C. ; et al.	2008-11-06
Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby App 20080254059 - Bett; Andrew J. ; et al.	2008-10-16
Vaccines for blocking transmission of plasmodium vivax Grant 7,407,658 - Kaslow , et al. August 5, 2	2008-08-05
Vaccines For Blocking Transmission Of Plasmodium Vivax App 20070110772 - Kaslow; David C. ; et al.	2007-05-17
Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications App 20070077257 - Emini; Emilio A. ; et al.	2007-04-05
Vaccines for blocking transmission of Plasmodium vivax Grant 7,192,934 - Kaslow , et al. March 20, 2	2007-03-20
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20070054395 - Emini; Emilio A. ; et al.	2007-03-08
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20050070017 - Emini, Emilio A. ; et al.	2005-03-31
Hepatitis c virus vaccine App 20040247615 - Emini, Emilio A ; et al.	2004-12-09
Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby App 20040191222 - Emini, Emilio A. ; et al.	2004-09-30
Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby App 20040185555 - Emini, Emilio A. ; et al.	2004-09-23
Transmission blocking immunogen from malaria Grant 6,780,417 - Kaslow , et al. August 24, 2	2004-08-24
Methods for propagating adenovirus and virus produced thereby App 20040106194 - Bett, Andrew J. ; et al.	2004-06-03
Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modifications App 20040101957 - Emini, Emilio A. ; et al.	2004-05-27
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications Grant 6,733,993 - Emini , et al. May 11, 2	2004-05-11
Transmission Blocking Vaccine Against Malaria App 20030049278 - KASLOW, DAVID C. ; et al.	2003-03-13
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20030044421 - Emini, Emilio A. ; et al.	2003-03-06
Transmission-blocking vaccine against malaria Grant 5,853,739 - Kaslow , et al. December 29, 1	1998-12-29
Cloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230 Grant 5,733,772 - Williamson , et al. March 31, 1	1998-03-31
Expression of the P. falciparum transmission-blocking antigen in yeast Grant 5,217,898 - Kaslow , et al. June 8, 1	1993-06-08

Company Registrations

NCAGE Code	4AUL2	KASLOW DAVID C
CAGE Code	4AUL2	KASLOW, DAVID C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.